Materialise, the Leuven-based additive manufacturing software and services provider, will spin off its RapidFit business unit into an independent, management-led company on April 30, 2026.

Materialise, the Leuven-based additive manufacturing software and services provider, will spin off its RapidFit business unit into an independent, management-led company on April 30, 2026. RapidFit specializes in the production of custom 3D-printed jigs, fixtures, and quality control tooling for the automotive and industrial manufacturing sectors. The separation allows the new entity to operate autonomously, while Materialise focuses its internal resources on its core medical and software segments. Jurgen Laudus, Vice President of Manufacturing at Materialise, confirmed that the move is designed to provide RapidFit with the operational flexibility required to pursue independent growth and market-specific partnerships.

This divestiture reflects a strategic narrowing of the Materialise portfolio to prioritize high-margin segments like medical implants and software development. In the competitive landscape of industrial tooling, RapidFit faces pressure from specialized service bureaus and internal OEM additive departments that increasingly utilize LPBF and FDM/FFF technologies for shop-floor automation. By shedding a service-heavy, hardware-intensive unit, Materialise is optimizing its balance sheet to better compete with software-centric rivals and specialized medical device manufacturers. The move highlights a broader trend where established AM firms are decoupling service-heavy manufacturing units from high-value software and medical intellectual property to improve capital efficiency.

For RapidFit, the success of this transition depends on its ability to maintain existing automotive client relationships without the backing of the Materialise infrastructure. Buyers and industrial partners should expect continuity in service delivery, though the independent entity will now need to independently secure its own supply chain for polymers and metal powders. This separation effectively removes a non-core manufacturing operation from the Materialise P&L, allowing the parent company to focus on its core software and medical market leadership.